Updated interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine
The interim recommendations for use of the use of the Janssen Ad26.COV2.S (COVID-19) vaccine have been updated to
reflect latest evidence.
For further information, see below:
Interim recommendations for use of the the Janssen Ad26.COV2.S (COVID-19) vaccine against COVID-19